Sorri M, Jokinen K, Palva A
Acta Otolaryngol Suppl. 1979;360:30-2. doi: 10.3109/00016487809123463.
DSCG was tested on 38 patients with perennial rhinitis in the form of a nasal spray (2%)in a double-blind cross-over trial. Few of the investigated parameters in the whole material showed any significant preference of DSCG. A marked drug order effect was shown; in the group receiving placebo first, most of the clinical parameters assessed both by the clinician and the patient were better for DSCG. A therapeutical trial with DSCG is worth trying in perennial rhinitis.
在一项双盲交叉试验中,以鼻喷雾剂(2%)的形式对38例常年性鼻炎患者进行了DSCG测试。在整个研究材料中,很少有研究参数显示出对DSCG有任何显著偏好。结果显示出明显的药物顺序效应;在首先接受安慰剂的组中,临床医生和患者评估的大多数临床参数在使用DSCG时表现更好。在常年性鼻炎中进行DSCG治疗试验值得一试。